GPT and diabetes mellitus: In addition, they increased alanine aminotransferase (ALT; OR 1.89, 95% CI 1.42–2.51), creatinine kinase (OR 1.45, 95% CI 1.09–1.93), and diabetes risk (OR 1.13, 95% CI 1.02–1.26), whereas PCSK9 inhibitors had no significant adverse effects [163].